PedAM

Pediatric Disease Annotations & Medicines

Disease	respiratory failure
Phenotype	C0034069\|pulmonary fibrosis
Sentences	10
PubMedID- 26314316	The irreversible and rapid progression of pulmonary fibrosis associated with respiratory failure is the main cause of death in the later stages of poisoning.
PubMedID- 23968871	Conclusions: we confirm that use of invasive mv for acute respiratory failure in patients with idiopathic pulmonary fibrosis or fibrosing idiopathic nonspecific interstitial pneumonia is associated with a high mortality; however, a subset of patients may be discharged alive from the intensive care unit and hospital, providing an opportunity to consider lung transplant in case of eligibility.
PubMedID- 25201432	Noninvasive ventilation in the event of acute respiratory failure in patients with idiopathic pulmonary fibrosis: waiting for.
PubMedID- 24768565	Noninvasive ventilation in the event of acute respiratory failure in patients with idiopathic pulmonary fibrosis.
PubMedID- 26568853	The clinical manifestation of paraquat poisoning can be categorized into three groups: 1) mild poisoning (< 20 mg paraquat ion per kilogram of body weight), in which the patients often have minor gastrointestinal symptoms and usually recover fully; 2) severe poisoning (20 - 40 mg paraquat ion per kilogram of body weight), in which patients develop acute renal failure, acute lung injury and progressive pulmonary fibrosis, which leads to respiratory failure 2 - 3 weeks after the ingestion of paraquat; 3) fulminant poisoning (> 40 mg paraquat ion per kilogram of body weight); this high concentration of paraquat establishes multiple organ failure, leading to death within hours to a few days after the ingestion (7).
PubMedID- 23272154	Introduction: paraquat poisoning is characterized by multi-organ failure and pulmonary fibrosis with respiratory failure, resulting in high mortality and morbidity.
PubMedID- 20852840	Prognostic impact of high-flow nasal cannula oxygen supply in an icu patient with pulmonary fibrosis complicated by acute respiratory failure.
PubMedID- 22984669	However, severe respiratory failure can leading to death, and pulmonary fibrosis may also lead to chronic dyspnea.
PubMedID- 20561836	Idiopathic pulmonary fibrosis results in scarring of the lung and respiratory failure, and has a median survival of 3 to 5 years from the time of diagnosis.
PubMedID- 23772158	It is characterized by nonproductive cough and dyspnea followed by rapidly progressive respiratory failure with pulmonary fibrosis showing with high mortality.

Page: 1